2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole

Catalog No. :
ACZWXU647
CAS No. :
1229584-17-1
Molecular Formula :
C15H19BN2O2
Molecular Weight :
270.14

IUPAC Name:2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole

2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$108.00Login to see priceIn stockInquiry
100mg98%$184.00Login to see priceIn stockIn stock
250mg98%$315.00Login to see priceIn stockIn stock
1g98%$825.00Login to see priceIn stockIn stock
5g98%$3300.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole
IUPAC Name2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazole
MDL No.MFCD18383629
Molecular FormulaC15H19BN2O2
Molecular Weight270.14
SMILESCC1(C)OB(OC1(C)C)C1=CC=C(C=C1)C1=NC=CN1
InChI KeyABLIMXXAJWRGPB-UHFFFAOYSA-N
Synonym1H-IMidazole, 2-[4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)phenyl]-;(4-(1H-IMIDAZOL-2-YL)PHENYL)BORONIC ACID PINACOL ESTER;1H-IMidazole, 2-[4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2...
CAS No.1229584-17-1
PubChem CID59619662

Synthetic Route by SureRoute

1. ACZWXU647 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYWXQ056 route compound structure diagram
    ACYWXQ056176961-53-8 In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACZWXU647 route product structure diagram
    ACZWXU6471229584-17-1 In Stock
Inquiry

2. ACZWXU647 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYWXQ056 route compound structure diagram
    ACYWXQ056176961-53-8 In Stock
  2. Then
  3. ACZWXU647 route product structure diagram
    ACZWXU6471229584-17-1 In Stock
Inquiry

Comments (0)